Active: new fund May 2026 Verified 4 Nov 2026
Ansa
New York venture firm making thesis-driven investments in Series A through C companies, with portfolio companies in AI, security and healthcare operations.
- Type
- VC firm
- Location
- New York, New York, United States
- Stages
- Series A, Series B, Growth
- Backs
- B2B software, Medtech and digital health, Consumer apps, Fintech
- Sectors
- AI, Cybersecurity, Healthtech and life sciences, Media
- Fund size / AUM
- $200M Ansa Capital Fund II (Form D offering, 2026)
- Latest fund or filing
- 13 May 2026
- Portfolio mix
- B2B software 37%; Medtech and digital health 15%; Consumer apps 15%; Fintech 15%; Climate and energy 7%; Crypto and web3 4%; Hardware 4%; Consumer products 4% (n=27)
- Website
- www.ansa.co
Fund filings (SEC Form D)
- Latest fund on file
- Ansa Capital Fund II
- Filed
- 13 May 2026 (new notice)
- Fund size
- $200M (total offering)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Ansa, the paid file holds: 4 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
Coram AI
Sources
- www.sec.gov/Archives/edgar/data/2127369/000212736926000002/
- adviserinfo.sec.gov/firm/summary/318183
- www.ansa.co/
- www.ansa.co/company
- www.ansa.co/about-us
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 84 lists
Series B media investors in the US (16)Media investors in New York (20)Growth-stage media investors in the US (22)Series B media investors (24)Series B investors in New York (29)Series B consumer investors in the US (29)Cybersecurity investors in New York (33)Series B medtech investors in the US (36)Series A media investors in the US (36)Series B cybersecurity investors in the US (37)Growth-stage media investors (45)Series A investors in New York (49)Medtech investors in New York (53)Growth-stage cybersecurity investors in the US (55)Growth-stage investors in New York (57)Series B medtech investors (57)Series A media investors (59)Series B consumer investors (59)Consumer investors in New York (59)Series B fintech investors in the US (59)Growth-stage consumer investors in the US (60)Series A cybersecurity investors in the US (64)Series B cybersecurity investors (65)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Series A medtech investors in the US (76)Series A consumer investors in the US (80)Growth-stage cybersecurity investors (92)Growth-stage fintech investors in the US (97)Fintech investors in New York (98)Healthtech investors in New York (100)Growth-stage medtech investors (107)Series B SaaS investors in the US (108)Series A cybersecurity investors (118)Growth-stage healthtech investors in the US (121)Growth-stage consumer investors (124)Series A medtech investors (125)Series B AI investors in the US (126)Series B fintech investors (127)Media venture capital firms in the US (135)SaaS investors in New York (138)Series A fintech investors in the US (145)Series A consumer investors (154)AI investors in New York (159)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)Series B SaaS investors (196)Media investors (200)Series B AI investors (204)Cybersecurity venture capital firms in the US (214)Growth-stage fintech investors (214)Series A SaaS investors in the US (256)Series A AI investors in the US (280)Growth-stage investors in the US (288)Series A fintech investors (294)Growth-stage AI investors (295)Cybersecurity investors (316)Growth-stage healthtech investors (316)Series B investors (339)Growth-stage SaaS investors (344)Consumer venture capital firms in the US (348)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Venture capital firms in New York (440)Medtech investors (457)Series A SaaS investors (475)Series A AI investors (500)Consumer investors (512)Fintech venture capital firms in the US (525)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Fintech investors (846)Series A investors (864)SaaS venture capital firms in the US (1,049)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Venture capital firms in the US (2,975)